FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308375595> ?p ?o ?g. }

• W4308375595 abstract "<h3>Background</h3> Tertiary lymphoid structures (TLS) in melanoma are associated with improved survival and response to checkpoint blockade therapy (CBT). However, whether and how TLS contribute to this response is unknown. If TLS contribute to the responses, they may be expected to contain higher proportions of T-cells with therapeutic potential, than tumor infiltrating lymphocytes outside of TLS. TCF1/TCF7 has been identified as a marker for a stem cell-like T-cell that mediates the proliferative response post-CBT in tumor infiltrating cells. We hypothesized that TLS would contain higher fractions of stem-like TCF7⁺ and TCF7⁺TOX⁺ T-cells poised to respond post-CBT. To address this hypothesis, we evaluated TLS and tumor sites of both desmoplastic and non-desmoplastic melanomas, for markers of stem like T-cells (TCF7, TOX). <h3>Methods</h3> Primary desmoplastic melanomas (PDM) and non-desmoplastic metastatic melanomas (NDMM) were evaluated for TLS presence (yes/no) and immune markers, by 7-color multiplex Immunofluorescence histology. Specimens were stained with the following two panels: TLS panel: CD20, CD3, CD8, PNAd, DC-Lamp, Ki67, and DAPI; T cell activity panel: CD3, CD8, CD20, Granzyme-b, TOX, TCF7, and DAPI. Lymphoid aggregates were identified as TLS if possessing organized T-cell and B-cell regions in addition to high endothelial venule-like vasculature (PNAd⁺). Cells were enumerated from TLS and tumor regions of TLS+ tumor specimens from PDM, and NDMM, with Halo software (Indica Labs). CD3⁺CD8⁺ (CD8⁺) cells and CD3⁺CD8^- (CD4⁺) cells were evaluated for activation markers, and the proportions of cells expressing activation markers was calculated. Statistical comparisons were done with unpaired Wilcoxon tests in RStudio. <h3>Results</h3> TLS were identified in 25 out of 39 evaluated (64%) PDM, and 37 of 111 (33%) NDMM. Comparing TLS to tumor outside the TLS, we found that PDM TLS contain significantly elevated proportions of CD8⁺TCF7⁺ cells and CD4⁺TCF7⁺ cells compared to tumor (table 1). NDMM TLS also contain elevated proportions of CD8⁺TCF7⁺ cells and CD4⁺TCF7⁺ cells relative to tumor (table 1). In addition, TLS in PDM and NDMM contain elevated proportions of CD8⁺TOX⁺TCF7⁺ cells and CD4⁺TOX⁺TCF7⁺ cells relative to their respective tumor (table 1). <h3>Conclusions</h3> The elevated proportion of TCF7⁺ T-cells, and TCF7⁺TOX⁺ T-cells in TLS from PDM and NDMM relative to their tumor suggests that stem-like T-cells are enriched in TLS, and that T-cell regeneration may be occurring there. Additionally, TLS may be helping in the maintenance or generation of TCF7⁺ T-cells in the tumor microenvironment." @default.
• W4308375595 created "2022-11-11" @default.
• W4308375595 creator A5003006025 @default.
• W4308375595 creator A5018417105 @default.
• W4308375595 creator A5065383881 @default.
• W4308375595 creator A5090865977 @default.
• W4308375595 date "2022-11-01" @default.
• W4308375595 modified "2023-09-25" @default.
• W4308375595 title "11 Tertiary lymphoid structures in melanomas harbor increased proportions of stem-like effector T-cells compared to tumor-infiltrating lymphocytes" @default.
• W4308375595 doi "https://doi.org/10.1136/jitc-2022-sitc2022.0011" @default.
• W4308375595 hasPublicationYear "2022" @default.
• W4308375595 type Work @default.
• W4308375595 citedByCount "0" @default.
• W4308375595 crossrefType "proceedings-article" @default.
• W4308375595 hasAuthorship W4308375595A5003006025 @default.
• W4308375595 hasAuthorship W4308375595A5018417105 @default.
• W4308375595 hasAuthorship W4308375595A5065383881 @default.
• W4308375595 hasAuthorship W4308375595A5090865977 @default.
• W4308375595 hasBestOaLocation W43083755951 @default.
• W4308375595 hasConcept C114684123 @default.
• W4308375595 hasConcept C136302470 @default.
• W4308375595 hasConcept C142724271 @default.
• W4308375595 hasConcept C167672396 @default.
• W4308375595 hasConcept C18031839 @default.
• W4308375595 hasConcept C203014093 @default.
• W4308375595 hasConcept C2779338263 @default.
• W4308375595 hasConcept C28328180 @default.
• W4308375595 hasConcept C502942594 @default.
• W4308375595 hasConcept C71924100 @default.
• W4308375595 hasConcept C86803240 @default.
• W4308375595 hasConcept C8891405 @default.
• W4308375595 hasConcept C95444343 @default.
• W4308375595 hasConceptScore W4308375595C114684123 @default.
• W4308375595 hasConceptScore W4308375595C136302470 @default.
• W4308375595 hasConceptScore W4308375595C142724271 @default.
• W4308375595 hasConceptScore W4308375595C167672396 @default.
• W4308375595 hasConceptScore W4308375595C18031839 @default.
• W4308375595 hasConceptScore W4308375595C203014093 @default.
• W4308375595 hasConceptScore W4308375595C2779338263 @default.
• W4308375595 hasConceptScore W4308375595C28328180 @default.
• W4308375595 hasConceptScore W4308375595C502942594 @default.
• W4308375595 hasConceptScore W4308375595C71924100 @default.
• W4308375595 hasConceptScore W4308375595C86803240 @default.
• W4308375595 hasConceptScore W4308375595C8891405 @default.
• W4308375595 hasConceptScore W4308375595C95444343 @default.
• W4308375595 hasLocation W43083755951 @default.
• W4308375595 hasOpenAccess W4308375595 @default.
• W4308375595 hasPrimaryLocation W43083755951 @default.
• W4308375595 hasRelatedWork W1994409433 @default.
• W4308375595 hasRelatedWork W2028265112 @default.
• W4308375595 hasRelatedWork W2386178746 @default.
• W4308375595 hasRelatedWork W2545840385 @default.
• W4308375595 hasRelatedWork W2592821367 @default.
• W4308375595 hasRelatedWork W2896243757 @default.
• W4308375595 hasRelatedWork W2996978872 @default.
• W4308375595 hasRelatedWork W2998106655 @default.
• W4308375595 hasRelatedWork W4210455029 @default.
• W4308375595 hasRelatedWork W4235088023 @default.
• W4308375595 isParatext "false" @default.
• W4308375595 isRetracted "false" @default.
• W4308375595 workType "article" @default.